Arg309

Site Information
DLKVPAGrGGQNLPT SwissProt Entrez-Gene
Blast this site against: NCBI SwissProt PDB
Site Group ID: 13247200

In vivo Characterization
Methods used to characterize site in vivo:	mass spectrometry ( 1 , 2 , 3 , 4 )
Disease tissue studied:	adrenal cancer ( 1 , 2 , 3 , 4 ) , pheochromocytoma ( 1 , 2 , 3 , 4 )
Relevant cell line - cell type - tissue:	PC-12 (chromaffin) ( 1 , 2 , 3 , 4 )

References
1	Zhou J (2009) CST Curation Set: 6812; Year: 2009; Biosample/Treatment: cell line, PC-12/NGF; Disease: pheochromocytoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: m1R Curated Info
2	Zhou J (2009) CST Curation Set: 6810; Year: 2009; Biosample/Treatment: cell line, PC-12/untreated; Disease: pheochromocytoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: m1R Curated Info
3	Zhou J (2009) CST Curation Set: 6809; Year: 2009; Biosample/Treatment: cell line, PC-12/untreated; Disease: pheochromocytoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: m1R Curated Info
4	Zhou J (2009) CST Curation Set: 6811; Year: 2009; Biosample/Treatment: cell line, PC-12/NGF; Disease: pheochromocytoma; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: m1R Curated Info